The graft-versus-leukemia effect
Effectors . | Targets . | |
|---|---|---|
| CD4+ T cells | HLA class II—restricted | |
| CD8+ T cells | HLA class I—restricted | |
| Leukemia-specific antigens | ||
| Minor histocompatability antigens | ||
| NK cells | Alloreactive group | |
| Dendritic cells, macrophages, cytokines | ||
Effectors . | Targets . | |
|---|---|---|
| CD4+ T cells | HLA class II—restricted | |
| CD8+ T cells | HLA class I—restricted | |
| Leukemia-specific antigens | ||
| Minor histocompatability antigens | ||
| NK cells | Alloreactive group | |
| Dendritic cells, macrophages, cytokines | ||
Different components of the immune system target leukemia cells for elimination. In the GVL effect, T cells and NK cells play a major role in eliminating leukemia cells. The target structures for immune attack by T cells may be leukemia-specific antigens or minor histocompatibility antigens, which are expressed on all cells or limited to expression on hematopoietic cells. NK cells attack allogeneic target cells which do not express class I ligands that interact with their KIR (alloreactive groups). Dendritic cells, macrophages, and cytokines play roles in modulating the GVL effect.